Recent federal legislation, along with newly proposed rules from the U.S. Department of Labor (DOL), is bringing rapid and consequential change to the pharmacy benefit management (PBM) landscape.

For self-funded employers, these developments are more than policy shifts. There are direct implications for contract terms, fiduciary exposure under ERISA, rebate treatment, pricing transparency, and overall pharmacy benefit strategy.

Join Transcarent for a timely briefing on the evolving regulatory environment. Regulatory and policy experts will provide a structured overview of newly enacted laws and pending DOL rulemaking, and Jon Koval, PharmD, Vice President, Value Based Pharmacy Care at Transcarent will offer a clinical and market perspective on how these changes may impact plan design, cost management, and Member experience.

This session is designed specifically for employer plan sponsors and benefits leaders seeking clarity and actionable guidance.

This webinar will:

1. Provide a deep-dive on the recently enacted PBM legislation and proposed Department of Labor rules affecting ERISA plan sponsors.

2. Examine fiduciary considerations, contractual implications, and compliance risks emerging from new transparency and compensation requirements.

3. Identify practical actions employers can take now to mitigate risk, strengthen oversight, and optimize their pharmacy benefit strategy amid regulatory change.